296 related articles for article (PubMed ID: 21130819)
1. Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
Kluza E; Yeo SY; Schmid S; van der Schaft DW; Boekhoven RW; Schiffelers RM; Storm G; Strijkers GJ; Nicolay K
J Control Release; 2011 Apr; 151(1):10-7. PubMed ID: 21130819
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.
Banciu M; Schiffelers RM; Fens MH; Metselaar JM; Storm G
J Control Release; 2006 Jun; 113(1):1-8. PubMed ID: 16707187
[TBL] [Abstract][Full Text] [Related]
3. Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation.
Coimbra M; Banciu M; Fens MH; de Smet L; Cabaj M; Metselaar JM; Storm G; Schiffelers RM
J Control Release; 2010 Dec; 148(3):303-10. PubMed ID: 20869410
[TBL] [Abstract][Full Text] [Related]
4. MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate.
Cittadino E; Ferraretto M; Torres E; Maiocchi A; Crielaard BJ; Lammers T; Storm G; Aime S; Terreno E
Eur J Pharm Sci; 2012 Mar; 45(4):436-41. PubMed ID: 21896328
[TBL] [Abstract][Full Text] [Related]
5. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.
Metselaar JM; Wauben MH; Wagenaar-Hilbers JP; Boerman OC; Storm G
Arthritis Rheum; 2003 Jul; 48(7):2059-66. PubMed ID: 12847701
[TBL] [Abstract][Full Text] [Related]
6. Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
Banciu M; Metselaar JM; Schiffelers RM; Storm G
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):101-10. PubMed ID: 18602825
[TBL] [Abstract][Full Text] [Related]
7. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
8. Multi-parametric assessment of the anti-angiogenic effects of liposomal glucocorticoids.
Kluza E; Heisen M; Schmid S; van der Schaft DW; Schiffelers RM; Storm G; ter Haar Romeny BM; Strijkers GJ; Nicolay K
Angiogenesis; 2011 May; 14(2):143-53. PubMed ID: 21225337
[TBL] [Abstract][Full Text] [Related]
9. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome.
Tagami T; Foltz WD; Ernsting MJ; Lee CM; Tannock IF; May JP; Li SD
Biomaterials; 2011 Sep; 32(27):6570-8. PubMed ID: 21641639
[TBL] [Abstract][Full Text] [Related]
10. Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide.
Hofkens W; van den Hoven JM; Pesman GJ; Nabbe KC; Sweep FC; Storm G; van den Berg WB; van Lent PL
Int J Pharm; 2011 Sep; 416(2):493-8. PubMed ID: 21382459
[TBL] [Abstract][Full Text] [Related]
11. Systemic anti-tumor activity of liposomal glucocorticoids.
Park K
J Control Release; 2011 Apr; 151(1):1. PubMed ID: 21440020
[No Abstract] [Full Text] [Related]
12. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
13. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor.
Abu Lila AS; Doi Y; Nakamura K; Ishida T; Kiwada H
J Control Release; 2010 Mar; 142(2):167-73. PubMed ID: 19861140
[TBL] [Abstract][Full Text] [Related]
14. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.
Schiffelers RM; Metselaar JM; Fens MH; Janssen AP; Molema G; Storm G
Neoplasia; 2005 Feb; 7(2):118-27. PubMed ID: 15802017
[TBL] [Abstract][Full Text] [Related]
15. Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis.
Hofkens W; Storm G; van den Berg WB; van Lent PL
Int J Pharm; 2011 Sep; 416(2):486-92. PubMed ID: 21382458
[TBL] [Abstract][Full Text] [Related]
16. The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate.
Smits EAW; Soetekouw JA; Pieters EHE; Smits CJP; de Wijs-Rot N; Vromans H
Invest New Drugs; 2019 Oct; 37(5):890-901. PubMed ID: 30547315
[TBL] [Abstract][Full Text] [Related]
17. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.
van der Valk FM; van Wijk DF; Lobatto ME; Verberne HJ; Storm G; Willems MC; Legemate DA; Nederveen AJ; Calcagno C; Mani V; Ramachandran S; Paridaans MP; Otten MJ; Dallinga-Thie GM; Fayad ZA; Nieuwdorp M; Schulte DM; Metselaar JM; Mulder WJ; Stroes ES
Nanomedicine; 2015 Jul; 11(5):1039-46. PubMed ID: 25791806
[TBL] [Abstract][Full Text] [Related]
18. Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application.
Abu Lila AS; Eldin NE; Ichihara M; Ishida T; Kiwada H
Int J Pharm; 2012 Nov; 438(1-2):176-83. PubMed ID: 22944302
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.
Banciu M; Metselaar JM; Schiffelers RM; Storm G
Neoplasia; 2008 Feb; 10(2):108-17. PubMed ID: 18283332
[TBL] [Abstract][Full Text] [Related]
20. Critical factors in the development of tumor-targeted anti-inflammatory nanomedicines.
Coimbra M; Crielaard BJ; Storm G; Schiffelers RM
J Control Release; 2012 Jun; 160(2):232-8. PubMed ID: 22062692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
